Cytokinetics, Inc. (CYTK)
70.91
-1.18
(-1.64%)
USD |
NASDAQ |
Aug 31, 16:00
71.00
+0.09
(+0.13%)
After-Hours: 04:52
Cytokinetics Total Long Term Debt (Quarterly) : 1.250B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.250B |
| March 31, 2026 | 1.268B |
| December 31, 2025 | 1.265B |
| September 30, 2025 | 1.176B |
| June 30, 2025 | 838.47M |
| March 31, 2025 | 771.48M |
| December 31, 2024 | 769.70M |
| September 30, 2024 | 770.77M |
| June 30, 2024 | 771.67M |
| March 31, 2024 | 736.69M |
| December 31, 2023 | 737.88M |
| September 30, 2023 | 731.24M |
| June 30, 2023 | 733.61M |
| March 31, 2023 | 735.96M |
| December 31, 2022 | 736.51M |
| September 30, 2022 | 725.18M |
| June 30, 2022 | 312.22M |
| March 31, 2022 | 309.98M |
| December 31, 2021 | 255.07M |
| September 30, 2021 | 226.26M |
| June 30, 2021 | 224.44M |
| March 31, 2021 | 223.02M |
| December 31, 2020 | 135.71M |
| September 30, 2020 | 134.02M |
| June 30, 2020 | 132.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 132.57M |
| December 31, 2019 | 131.45M |
| September 30, 2019 | 185.74M |
| June 30, 2019 | 181.16M |
| March 31, 2019 | 175.17M |
| December 31, 2018 | 42.41M |
| September 30, 2018 | 159.62M |
| June 30, 2018 | 145.51M |
| March 31, 2018 | 140.75M |
| December 31, 2017 | 31.78M |
| September 30, 2017 | 130.88M |
| June 30, 2017 | 126.82M |
| March 31, 2017 | 122.95M |
| December 31, 2016 | 29.88M |
| September 30, 2016 | 29.74M |
| June 30, 2016 | 29.60M |
| March 31, 2016 | 29.47M |
| December 31, 2015 | 14.64M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 44.59B |
| Krystal Biotech, Inc. | 7.045M |
| Ionis Pharmaceuticals, Inc. | 2.189B |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Alnylam Pharmaceuticals, Inc. | 2.942B |